Skip to content

The role of different products for the treatment of tooth sensitivity

The role of bioactive, resinous and fluoridated agents in the treatment of dentin hypersensitivity and their interaction with sound and eroded dentin: in vitro and clinical investigations

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
REBEC
Registry ID
RBR-3424pzq
Enrollment
Unknown
Registered
2021-02-10
Start date
2021-01-10
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

clinical trial

Interventions

BioMin F Group: 20 participants with one tooth with dentin hypersensitivity greater than or equal to 4 on the visual analog scale after an evaporative stimulus and after a tactile stimulus. Participan

Sponsors

Faculdade de Odontologia de Bauru
Lead Sponsor
Faculdade de Odontologia de Bauru
Collaborator

Eligibility

Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Volunters older than 18 years old; with one tooth with dentin hypersensitivity igual to or higher than 4.

Exclusion criteria

Exclusion criteria: Patients with active caries lesions; defective restorations on selected teeth; structural loss of dentin that requires restorative or periodontal treatment; who has used any professional desensitizing agent in the past 6 months; use of some desensitizing toothpaste in the last 3 months; who uses anti-inflammatory medicine during the study period; patients using orthodontic appliances; smokers; pregnant women.

Design outcomes

Primary

MeasureTime frame
The reduction of dentin hypersensitivity verified immediately after the first use of the product, after 1 month, 3 months and 6 months will be evaluated by the use of the visual analog scale associated with evaporative and tactile stimuli in sensitive teeth, and its influence on the related quality of life oral health measured by changing the score of the OHIP-14 questionnaire, and the differences will be assessed based on the finding of a variation of at least 5% in the measurements between periods.

Countries

Brazil

Contacts

Public ContactVictor Mosquim
mosquim.victor@gmail.com+55 14 981254593

Outcome results

None listed

Source: REBEC (via WHO ICTRP)